This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Depardieu, F.
Right arrow Articles by Courvalin, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Depardieu, F.
Right arrow Articles by Courvalin, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2004, p. 3892-3904, Vol. 48, No. 10
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.10.3892-3904.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

VanD-Type Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis

Florence Depardieu,1 Mathias Kolbert,1,{dagger} Hendrik Pruul,2 Jan Bell,3 and Patrice Courvalin1*

Unité des Agents Antibactériens, Institut Pasteur, Paris, France,1 Flinders Medical Centre, Adelaide,2 Department of Infectious Diseases, Women's and Children's Hospital, North Adelaide, Australia3

Received 24 February 2004/ Returned for modification 19 April 2004/ Accepted 13 May 2004

Enterococcus faecium clinical isolates A902 and BM4538, which were resistant to relatively high levels of vancomycin (128 and 64 µg/ml, respectively) and to low levels of teicoplanin (4 µg/ml), and Enterococcus faecalis clinical isolates BM4539 and BM4540, which were resistant to moderate levels of vancomycin (16 µg/ml) and susceptible to teicoplanin (0.25 µg/ml), were studied. They were constitutively resistant by synthesis of peptidoglycan precursors ending with D-alanyl-D-lactate and harbored a chromosomal vanD gene cluster which was not transferable by conjugation to other enterococci. VanXD activity, which is not required in the absence of D-Ala-D-Ala, was low in the four strains, although none of the conserved residues was mutated; and the constitutive VanYD activity in the membrane fractions was inhibited by penicillin G. The mutations E13G in the region of D-alanine:D-alanine ligase (which is implicated in D-Ala1 binding in A902) and S319N of the serine involved in ATP binding in BM4538 and a 7-bp insertion at different locations in BM4539 and BM4540 (which led to putative truncated proteins) led to the production of an impaired enzyme and accounted for the lack of D-Ala-D-Ala-containing peptidoglycan precursors. The same 7-bp insertion in vanSD of BM4539 and BM4540 and a 1-bp deletion in vanSD of A902, which in each case led to a putative truncated and presumably nonfunctional protein, could account for the constitutive resistance. Strain BM4538, with a functional VanSD, had a G140E mutation in VanRD that could be responsible for constitutive glycopeptide resistance. This would represent the first example of constitutive van gene expression due to a mutation in the structural gene for a VanR transcriptional activator. Study of these four additional strains that could be distinguished on the basis of their various assortments of mutations confirmed that all VanD-type strains isolated so far have mutations in the ddl housekeeping gene and in the acquired vanSD or vanRD gene that lead to constitutive resistance to vancomycin.

* Corresponding author. Mailing address: Unité des Agents Antibactériens, Institut Pasteur, 25, rue du Docteur Roux, 75724 Paris Cedex 15, France. Phone: (33) (1) 45 68 83 21. Fax: (33) (1) 45 68 83 19. E-mail: pcourval{at}pasteur.fr.

{dagger} Present address: Mathias Kolbert, Bioscientia, 55218 Ingelheim, Germany.

Antimicrobial Agents and Chemotherapy, October 2004, p. 3892-3904, Vol. 48, No. 10
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.10.3892-3904.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Kato, Y., Suzuki, T., Ida, T., Maebashi, K. (2009). Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR. J Antimicrob Chemother 0: dkp394v1-dkp394 [Abstract] [Full Text]  
  • Depardieu, F., Foucault, M.-L., Bell, J., Dubouix, A., Guibert, M., Lavigne, J.-P., Levast, M., Courvalin, P. (2009). New Combinations of Mutations in VanD-Type Vancomycin-Resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium Strains. Antimicrob. Agents Chemother. 53: 1952-1963 [Abstract] [Full Text]  
  • San Millan, A., Depardieu, F., Godreuil, S., Courvalin, P. (2009). VanB-Type Enterococcus faecium Clinical Isolate Successively Inducibly Resistant to, Dependent on, and Constitutively Resistant to Vancomycin. Antimicrob. Agents Chemother. 53: 1974-1982 [Abstract] [Full Text]  
  • Domingo, M.-C., Huletsky, A., Giroux, R., Picard, F. J., Bergeron, M. G. (2007). vanD and vanG-Like Gene Clusters in a Ruminococcus Species Isolated from Human Bowel Flora. Antimicrob. Agents Chemother. 51: 4111-4117 [Abstract] [Full Text]  
  • Rea, M. C., Clayton, E., O'Connor, P. M., Shanahan, F., Kiely, B., Ross, R. P., Hill, C. (2007). Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains. J Med Microbiol 56: 940-946 [Abstract] [Full Text]  
  • Beltrametti, F., Consolandi, A., Carrano, L., Bagatin, F., Rossi, R., Leoni, L., Zennaro, E., Selva, E., Marinelli, F. (2007). Resistance to Glycopeptide Antibiotics in the Teicoplanin Producer Is Mediated by van Gene Homologue Expression Directing the Synthesis of a Modified Cell Wall Peptidoglycan. Antimicrob. Agents Chemother. 51: 1135-1141 [Abstract] [Full Text]  
  • Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., Courvalin, P. (2007). Modes and Modulations of Antibiotic Resistance Gene Expression. Clin. Microbiol. Rev. 20: 79-114 [Abstract] [Full Text]  
  • Tanimoto, K., Nomura, T., Maruyama, H., Tomita, H., Shibata, N., Arakawa, Y., Ike, Y. (2006). First VanD-Type Vancomycin-Resistant Enterococcus raffinosus Isolate. Antimicrob. Agents Chemother. 50: 3966-3967 [Full Text]  
  • Camargo, I. L. B. C., Dalla Costa, L. M., Woodford, N., Gilmore, M. S., Darini, A. L. C. (2006). Sequence Analysis of Enterococcus faecium Strain 10/96A (VanD4), the Original Vancomycin-Resistant E. faecium Strain in Brazil.. J. Clin. Microbiol. 44: 2635-2637 [Abstract] [Full Text]  
  • Boyd, D. A., Miller, M. A., Mulvey, M. R. (2006). Enterococcus gallinarum N04-0414 Harbors a VanD-Type Vancomycin Resistance Operon and Does Not Contain a D-Alanine:D-Alanine 2 (ddl2) Gene. Antimicrob. Agents Chemother. 50: 1067-1070 [Abstract] [Full Text]  
  • Lavigne, J.-P., Marchandin, H., Bouziges, N., Sotto, A. (2005). First Infection with VanD-Type Glycopeptide-Resistant Enterococcus faecium in Europe. J. Clin. Microbiol. 43: 3512-3515 [Abstract] [Full Text]  
  • Depardieu, F., Perichon, B., Courvalin, P. (2004). Detection of the van Alphabet and Identification of Enterococci and Staphylococci at the Species Level by Multiplex PCR. J. Clin. Microbiol. 42: 5857-5860 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»